Fasoracetam

N/A

Report date: 2025/04/20 20:00:03
NME

Base Information

Drug NameFasoracetam
Drug Alias Name法索西坦fasoracetamfasoracetamumfasoracetam monohydrate(5R)-5-(pyridine-1-carbonyl)pyrrolidin-2-one monohydrate +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-Aminobutyric Acid B Receptor antagonists
TargetsGamma-Aminobutyric Acid B Receptor
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityDiGeorge Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNippon Shinyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAevi Genomic Medicine Llc
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with HyperactivityDiGeorge Syndrome

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG